Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy to ambulatory people but maintain a halt it implemented June 15 for ...

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location. According to a mass layoff notice filed with the state, biotech company Sarepta ...

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...

Seven Ohio companies reported 591 layoffs in June, per WARN Act notices filed with the state. Largest cuts came from Ohio ...

COLUMBUS, Ohio — A biotechnology company is conducting a layoff of nearly 500 employees, including 80 in Franklin County, according to a letter from Sarepta Therapeutics. The company, which ...

Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning By Gabrielle Masson Jul 16, 2025 4:59pm Sarepta Sarepta Therapeutics biotech layoffs Duchenne muscular dystrophy (DMD) ...

Sarepta Therapeutics is facing a challenging period after the deaths of two patients who received its gene therapy for Duchenne muscular dystrophy. Biotech's Future - Innovation, AI and our ...

Sarepta Therapeutics to lay off 493 workers, including 80 in Ohio, amid FDA probe, stock plunge, and concerns over Duchenne gene therapy Elevidys.

A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.